nodes	percent_of_prediction	percent_of_DWPC	metapath
Nadolol—ADRB1—type 1 diabetes mellitus	0.866	1	CbGaD
Nadolol—Pemphigoid—Ramipril—type 1 diabetes mellitus	0.0189	0.234	CcSEcCtD
Nadolol—Alopecia reversible—Ramipril—type 1 diabetes mellitus	0.0104	0.129	CcSEcCtD
Nadolol—Sleep disturbance—Ramipril—type 1 diabetes mellitus	0.00423	0.0522	CcSEcCtD
Nadolol—Laryngospasm—Ramipril—type 1 diabetes mellitus	0.00317	0.0392	CcSEcCtD
Nadolol—Sleep disorder—Ramipril—type 1 diabetes mellitus	0.00199	0.0246	CcSEcCtD
Nadolol—Nasal congestion—Ramipril—type 1 diabetes mellitus	0.00189	0.0233	CcSEcCtD
Nadolol—Libido decreased—Ramipril—type 1 diabetes mellitus	0.00185	0.0229	CcSEcCtD
Nadolol—Amnesia—Ramipril—type 1 diabetes mellitus	0.00183	0.0226	CcSEcCtD
Nadolol—Pirbuterol—ADRB1—type 1 diabetes mellitus	0.00182	0.204	CrCbGaD
Nadolol—Cardiac failure—Ramipril—type 1 diabetes mellitus	0.00176	0.0218	CcSEcCtD
Nadolol—Disturbance in sexual arousal—Ramipril—type 1 diabetes mellitus	0.00171	0.0211	CcSEcCtD
Nadolol—Levobunolol—ADRB1—type 1 diabetes mellitus	0.00163	0.181	CrCbGaD
Nadolol—Gastritis—Ramipril—type 1 diabetes mellitus	0.00152	0.0188	CcSEcCtD
Nadolol—Bronchospasm—Ramipril—type 1 diabetes mellitus	0.00146	0.0181	CcSEcCtD
Nadolol—Abdominal discomfort—Ramipril—type 1 diabetes mellitus	0.00142	0.0176	CcSEcCtD
Nadolol—Carteolol—ADRB1—type 1 diabetes mellitus	0.00138	0.154	CrCbGaD
Nadolol—Erectile dysfunction—Ramipril—type 1 diabetes mellitus	0.00137	0.0169	CcSEcCtD
Nadolol—Weight increased—Ramipril—type 1 diabetes mellitus	0.00135	0.0167	CcSEcCtD
Nadolol—Conjunctivitis—Ramipril—type 1 diabetes mellitus	0.00129	0.0159	CcSEcCtD
Nadolol—Sweating—Ramipril—type 1 diabetes mellitus	0.00127	0.0157	CcSEcCtD
Nadolol—Agranulocytosis—Ramipril—type 1 diabetes mellitus	0.00124	0.0153	CcSEcCtD
Nadolol—Bupranolol—ADRB1—type 1 diabetes mellitus	0.00118	0.131	CrCbGaD
Nadolol—Visual impairment—Ramipril—type 1 diabetes mellitus	0.00115	0.0142	CcSEcCtD
Nadolol—Tinnitus—Ramipril—type 1 diabetes mellitus	0.00111	0.0137	CcSEcCtD
Nadolol—Salbutamol—ADRB1—type 1 diabetes mellitus	0.0011	0.123	CrCbGaD
Nadolol—Penbutolol—ADRB1—type 1 diabetes mellitus	0.00107	0.12	CrCbGaD
Nadolol—Alopecia—Ramipril—type 1 diabetes mellitus	0.00105	0.013	CcSEcCtD
Nadolol—Syncope—Ramipril—type 1 diabetes mellitus	0.000928	0.0115	CcSEcCtD
Nadolol—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.00091	0.0113	CcSEcCtD
Nadolol—Cough—Ramipril—type 1 diabetes mellitus	0.000903	0.0112	CcSEcCtD
Nadolol—Chest pain—Ramipril—type 1 diabetes mellitus	0.000881	0.0109	CcSEcCtD
Nadolol—Dry mouth—Ramipril—type 1 diabetes mellitus	0.000862	0.0107	CcSEcCtD
Nadolol—Oedema—Ramipril—type 1 diabetes mellitus	0.000845	0.0104	CcSEcCtD
Nadolol—Shock—Ramipril—type 1 diabetes mellitus	0.000831	0.0103	CcSEcCtD
Nadolol—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.000817	0.0101	CcSEcCtD
Nadolol—Anorexia—Ramipril—type 1 diabetes mellitus	0.000805	0.00996	CcSEcCtD
Nadolol—Hypotension—Ramipril—type 1 diabetes mellitus	0.00079	0.00976	CcSEcCtD
Nadolol—Pindolol—ADRB1—type 1 diabetes mellitus	0.000775	0.0865	CrCbGaD
Nadolol—Insomnia—Ramipril—type 1 diabetes mellitus	0.000764	0.00945	CcSEcCtD
Nadolol—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.000759	0.00938	CcSEcCtD
Nadolol—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.000753	0.00932	CcSEcCtD
Nadolol—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.000744	0.0092	CcSEcCtD
Nadolol—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.000735	0.00908	CcSEcCtD
Nadolol—Fatigue—Ramipril—type 1 diabetes mellitus	0.000729	0.00901	CcSEcCtD
Nadolol—Constipation—Ramipril—type 1 diabetes mellitus	0.000723	0.00894	CcSEcCtD
Nadolol—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.000668	0.00826	CcSEcCtD
Nadolol—Asthenia—Ramipril—type 1 diabetes mellitus	0.000606	0.0075	CcSEcCtD
Nadolol—Pruritus—Ramipril—type 1 diabetes mellitus	0.000598	0.00739	CcSEcCtD
Nadolol—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.000578	0.00715	CcSEcCtD
Nadolol—Dizziness—Ramipril—type 1 diabetes mellitus	0.000559	0.00691	CcSEcCtD
Nadolol—Vomiting—Ramipril—type 1 diabetes mellitus	0.000537	0.00664	CcSEcCtD
Nadolol—Rash—Ramipril—type 1 diabetes mellitus	0.000533	0.00659	CcSEcCtD
Nadolol—Dermatitis—Ramipril—type 1 diabetes mellitus	0.000532	0.00658	CcSEcCtD
Nadolol—Nausea—Ramipril—type 1 diabetes mellitus	0.000502	0.00621	CcSEcCtD
Nadolol—ABCB1—Allograft Rejection—IL4—type 1 diabetes mellitus	0.000126	0.00283	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—CCL20—type 1 diabetes mellitus	0.000125	0.00281	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—CCL11—type 1 diabetes mellitus	0.000125	0.00281	CbGpPWpGaD
Nadolol—ADRB3—GPCR ligand binding—CXCL10—type 1 diabetes mellitus	0.000124	0.00278	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—SLC29A3—type 1 diabetes mellitus	0.000124	0.00278	CbGpPWpGaD
Nadolol—ABCB1—Allograft Rejection—HLA-B—type 1 diabetes mellitus	0.000124	0.00277	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—GAL—type 1 diabetes mellitus	0.000123	0.00276	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	0.000122	0.00273	CbGpPWpGaD
Nadolol—ABCB1—Allograft Rejection—FASLG—type 1 diabetes mellitus	0.000121	0.00271	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—CHRM2—type 1 diabetes mellitus	0.00012	0.0027	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—CHRM2—type 1 diabetes mellitus	0.000118	0.00264	CbGpPWpGaD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—SST—type 1 diabetes mellitus	0.000117	0.00261	CbGpPWpGaD
Nadolol—ABCB1—Allograft Rejection—IL2RA—type 1 diabetes mellitus	0.000116	0.00259	CbGpPWpGaD
Nadolol—ABCB1—HIF-1-alpha transcription factor network—NOS2—type 1 diabetes mellitus	0.000115	0.00258	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	0.000115	0.00257	CbGpPWpGaD
Nadolol—ABCB1—Allograft Rejection—HLA-A—type 1 diabetes mellitus	0.000115	0.00257	CbGpPWpGaD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—SST—type 1 diabetes mellitus	0.000114	0.00256	CbGpPWpGaD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRB1—type 1 diabetes mellitus	0.000114	0.00254	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—GAL—type 1 diabetes mellitus	0.000112	0.00251	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—CCL20—type 1 diabetes mellitus	0.000111	0.00248	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—CCL11—type 1 diabetes mellitus	0.000111	0.00248	CbGpPWpGaD
Nadolol—ABCB1—Allograft Rejection—HLA-DRB1—type 1 diabetes mellitus	0.000105	0.00234	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	0.000104	0.00233	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	0.000103	0.00231	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—IAPP—type 1 diabetes mellitus	0.000103	0.0023	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—IAPP—type 1 diabetes mellitus	0.000101	0.00227	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—IAPP—type 1 diabetes mellitus	9.9e-05	0.00222	CbGpPWpGaD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL10—type 1 diabetes mellitus	9.69e-05	0.00217	CbGpPWpGaD
Nadolol—ABCB1—Allograft Rejection—CD80—type 1 diabetes mellitus	9.67e-05	0.00217	CbGpPWpGaD
Nadolol—ADRB3—GPCR ligand binding—CCR5—type 1 diabetes mellitus	9.64e-05	0.00216	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	9.63e-05	0.00216	CbGpPWpGaD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL10—type 1 diabetes mellitus	9.48e-05	0.00212	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	9.35e-05	0.00209	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—SST—type 1 diabetes mellitus	8.88e-05	0.00199	CbGpPWpGaD
Nadolol—ADRB1—GPCRs, Class A Rhodopsin-like—CCR5—type 1 diabetes mellitus	8.77e-05	0.00196	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—IAPP—type 1 diabetes mellitus	8.75e-05	0.00196	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—SST—type 1 diabetes mellitus	8.69e-05	0.00195	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—ADRB1—type 1 diabetes mellitus	8.65e-05	0.00194	CbGpPWpGaD
Nadolol—ADRB2—GPCRs, Class A Rhodopsin-like—CCR5—type 1 diabetes mellitus	8.58e-05	0.00192	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—SST—type 1 diabetes mellitus	8.46e-05	0.00189	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	8.42e-05	0.00189	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—GCG—type 1 diabetes mellitus	7.92e-05	0.00177	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—GCG—type 1 diabetes mellitus	7.74e-05	0.00173	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—SST—type 1 diabetes mellitus	7.68e-05	0.00172	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	7.65e-05	0.00171	CbGpPWpGaD
Nadolol—ABCB1—Allograft Rejection—IFNG—type 1 diabetes mellitus	7.64e-05	0.00171	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—GCG—type 1 diabetes mellitus	7.54e-05	0.00169	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—G6PC2—type 1 diabetes mellitus	7.52e-05	0.00168	CbGpPWpGaD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR5—type 1 diabetes mellitus	7.52e-05	0.00168	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—CXCL10—type 1 diabetes mellitus	7.38e-05	0.00165	CbGpPWpGaD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR5—type 1 diabetes mellitus	7.35e-05	0.00165	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—GAL—type 1 diabetes mellitus	7.32e-05	0.00164	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	7.26e-05	0.00162	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	7.24e-05	0.00162	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—CXCL10—type 1 diabetes mellitus	7.22e-05	0.00162	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—GAL—type 1 diabetes mellitus	7.16e-05	0.0016	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	7.08e-05	0.00159	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	7.05e-05	0.00158	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	7.03e-05	0.00157	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—GCG—type 1 diabetes mellitus	6.85e-05	0.00153	CbGpPWpGaD
Nadolol—ABCB1—Allograft Rejection—IL1B—type 1 diabetes mellitus	6.82e-05	0.00153	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	6.81e-05	0.00152	CbGpPWpGaD
Nadolol—ABCB1—Allograft Rejection—CASP3—type 1 diabetes mellitus	6.8e-05	0.00152	CbGpPWpGaD
Nadolol—ABCB1—Allograft Rejection—IL2—type 1 diabetes mellitus	6.79e-05	0.00152	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	6.66e-05	0.00149	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—GAL—type 1 diabetes mellitus	6.65e-05	0.00149	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—GAL—type 1 diabetes mellitus	6.62e-05	0.00148	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	6.59e-05	0.00148	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—CCL20—type 1 diabetes mellitus	6.58e-05	0.00147	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—CCL11—type 1 diabetes mellitus	6.58e-05	0.00147	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CCL11—type 1 diabetes mellitus	6.55e-05	0.00147	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CCL20—type 1 diabetes mellitus	6.55e-05	0.00147	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—ABCC8—type 1 diabetes mellitus	6.52e-05	0.00146	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—GAL—type 1 diabetes mellitus	6.51e-05	0.00146	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—CCL11—type 1 diabetes mellitus	6.43e-05	0.00144	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—CCL20—type 1 diabetes mellitus	6.43e-05	0.00144	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—VAV1—type 1 diabetes mellitus	6.4e-05	0.00143	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	6.38e-05	0.00143	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—type 1 diabetes mellitus	6.21e-05	0.00139	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	6.18e-05	0.00138	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CHRM2—type 1 diabetes mellitus	6.15e-05	0.00138	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	6.11e-05	0.00137	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	6.05e-05	0.00135	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	5.98e-05	0.00134	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—type 1 diabetes mellitus	5.96e-05	0.00134	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—CCR5—type 1 diabetes mellitus	5.72e-05	0.00128	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	5.72e-05	0.00128	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—CCR5—type 1 diabetes mellitus	5.6e-05	0.00125	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	5.59e-05	0.00125	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	5.55e-05	0.00124	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—ITPR3—type 1 diabetes mellitus	5.52e-05	0.00124	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	5.45e-05	0.00122	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	5.43e-05	0.00122	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	5.37e-05	0.0012	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—SH2B3—type 1 diabetes mellitus	5.2e-05	0.00116	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—IAPP—type 1 diabetes mellitus	5.19e-05	0.00116	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—APOC3—type 1 diabetes mellitus	5.17e-05	0.00116	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—IAPP—type 1 diabetes mellitus	5.17e-05	0.00116	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—IAPP—type 1 diabetes mellitus	5.08e-05	0.00114	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—type 1 diabetes mellitus	5.06e-05	0.00113	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—SST—type 1 diabetes mellitus	5.02e-05	0.00112	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—SLC18A2—type 1 diabetes mellitus	4.99e-05	0.00112	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—CCR5—type 1 diabetes mellitus	4.95e-05	0.00111	CbGpPWpGaD
Nadolol—ABCB1—Allograft Rejection—TNF—type 1 diabetes mellitus	4.95e-05	0.00111	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—SST—type 1 diabetes mellitus	4.91e-05	0.0011	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	4.89e-05	0.00109	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	4.88e-05	0.00109	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—CP—type 1 diabetes mellitus	4.6e-05	0.00103	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—SLC11A1—type 1 diabetes mellitus	4.56e-05	0.00102	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—SST—type 1 diabetes mellitus	4.56e-05	0.00102	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—SST—type 1 diabetes mellitus	4.54e-05	0.00102	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—ADRB1—type 1 diabetes mellitus	4.52e-05	0.00101	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—GCG—type 1 diabetes mellitus	4.47e-05	0.001	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—SST—type 1 diabetes mellitus	4.46e-05	0.000999	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	4.44e-05	0.000994	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—GCG—type 1 diabetes mellitus	4.38e-05	0.00098	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—type 1 diabetes mellitus	4.36e-05	0.000977	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	4.31e-05	0.000964	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	4.21e-05	0.000943	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	4.18e-05	0.000937	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	4.17e-05	0.000934	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	4.09e-05	0.000916	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	4.08e-05	0.000914	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—GCG—type 1 diabetes mellitus	4.06e-05	0.00091	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—GCG—type 1 diabetes mellitus	4.04e-05	0.000906	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—GCG—type 1 diabetes mellitus	3.97e-05	0.00089	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—GAL—type 1 diabetes mellitus	3.93e-05	0.00088	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	3.91e-05	0.000876	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	3.89e-05	0.000872	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CCL11—type 1 diabetes mellitus	3.88e-05	0.00087	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CCL20—type 1 diabetes mellitus	3.88e-05	0.00087	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—GAL—type 1 diabetes mellitus	3.84e-05	0.000861	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	3.83e-05	0.000857	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CCL20—type 1 diabetes mellitus	3.8e-05	0.000851	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CCL11—type 1 diabetes mellitus	3.8e-05	0.000851	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—VAV1—type 1 diabetes mellitus	3.8e-05	0.000851	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	3.79e-05	0.000848	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—VAV1—type 1 diabetes mellitus	3.78e-05	0.000847	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CXCL10—type 1 diabetes mellitus	3.77e-05	0.000844	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—HBA2—type 1 diabetes mellitus	3.75e-05	0.000839	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—VAV1—type 1 diabetes mellitus	3.72e-05	0.000832	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	3.71e-05	0.00083	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CHRM2—type 1 diabetes mellitus	3.65e-05	0.000818	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CHRM2—type 1 diabetes mellitus	3.57e-05	0.0008	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—G6PC2—type 1 diabetes mellitus	3.52e-05	0.000789	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—TYK2—type 1 diabetes mellitus	3.44e-05	0.00077	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—IGF2—type 1 diabetes mellitus	3.42e-05	0.000767	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—type 1 diabetes mellitus	3.36e-05	0.000752	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CD86—type 1 diabetes mellitus	3.3e-05	0.000738	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—ITPR3—type 1 diabetes mellitus	3.28e-05	0.000734	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	3.23e-05	0.000724	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—ITPR3—type 1 diabetes mellitus	3.21e-05	0.000718	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	3.19e-05	0.000714	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	3.16e-05	0.000709	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—IL2—type 1 diabetes mellitus	3.15e-05	0.000705	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—E2F1—type 1 diabetes mellitus	3.13e-05	0.000701	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	3.12e-05	0.000698	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—SH2B3—type 1 diabetes mellitus	3.09e-05	0.000691	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—APOC3—type 1 diabetes mellitus	3.07e-05	0.000687	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—IAPP—type 1 diabetes mellitus	3.07e-05	0.000687	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—ABCC8—type 1 diabetes mellitus	3.06e-05	0.000684	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—SH2B3—type 1 diabetes mellitus	3.02e-05	0.000676	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—APOC3—type 1 diabetes mellitus	3e-05	0.000672	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—IAPP—type 1 diabetes mellitus	3e-05	0.000672	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—ERBB3—type 1 diabetes mellitus	2.97e-05	0.000666	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—CCR5—type 1 diabetes mellitus	2.94e-05	0.000658	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CCR5—type 1 diabetes mellitus	2.92e-05	0.000655	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	2.89e-05	0.000648	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—IL2RA—type 1 diabetes mellitus	2.88e-05	0.000645	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—CCR5—type 1 diabetes mellitus	2.87e-05	0.000643	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—IL2—type 1 diabetes mellitus	2.86e-05	0.00064	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	2.83e-05	0.000634	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—SST—type 1 diabetes mellitus	2.69e-05	0.000603	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—SST—type 1 diabetes mellitus	2.63e-05	0.00059	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—ADRB1—type 1 diabetes mellitus	2.62e-05	0.000587	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 1 diabetes mellitus	2.56e-05	0.000574	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 1 diabetes mellitus	2.44e-05	0.000547	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—KCNJ11—type 1 diabetes mellitus	2.42e-05	0.000541	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CD80—type 1 diabetes mellitus	2.4e-05	0.000539	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—GCG—type 1 diabetes mellitus	2.4e-05	0.000537	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—GCG—type 1 diabetes mellitus	2.35e-05	0.000526	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	2.31e-05	0.000517	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—INS—type 1 diabetes mellitus	2.27e-05	0.000509	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	2.26e-05	0.000506	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—VAV1—type 1 diabetes mellitus	2.24e-05	0.000502	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CXCL10—type 1 diabetes mellitus	2.24e-05	0.000501	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—IGF1—type 1 diabetes mellitus	2.2e-05	0.000492	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—VAV1—type 1 diabetes mellitus	2.19e-05	0.000492	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CXCL10—type 1 diabetes mellitus	2.19e-05	0.00049	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—EGFR—type 1 diabetes mellitus	2.19e-05	0.00049	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	2.04e-05	0.000457	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—ITPR3—type 1 diabetes mellitus	2.04e-05	0.000457	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—IGF2—type 1 diabetes mellitus	2.03e-05	0.000455	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—TYK2—type 1 diabetes mellitus	2.03e-05	0.000455	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—TYK2—type 1 diabetes mellitus	2e-05	0.000447	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.99e-05	0.000446	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.99e-05	0.000445	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CD86—type 1 diabetes mellitus	1.96e-05	0.000438	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—HBA1—type 1 diabetes mellitus	1.92e-05	0.00043	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CD86—type 1 diabetes mellitus	1.91e-05	0.000429	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—APOC3—type 1 diabetes mellitus	1.91e-05	0.000427	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—GSTT1—type 1 diabetes mellitus	1.87e-05	0.000419	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.87e-05	0.000419	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.86e-05	0.000416	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.83e-05	0.000409	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.82e-05	0.000407	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.76e-05	0.000395	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.74e-05	0.000389	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.73e-05	0.000387	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.71e-05	0.000383	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.7e-05	0.00038	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.7e-05	0.00038	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CASP3—type 1 diabetes mellitus	1.69e-05	0.000379	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—IL2—type 1 diabetes mellitus	1.69e-05	0.000378	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—IL6—type 1 diabetes mellitus	1.68e-05	0.000376	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.67e-05	0.000375	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.66e-05	0.000372	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	1.64e-05	0.000368	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—GCG—type 1 diabetes mellitus	1.49e-05	0.000334	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CD80—type 1 diabetes mellitus	1.43e-05	0.00032	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.42e-05	0.000318	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CD80—type 1 diabetes mellitus	1.4e-05	0.000313	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—INS—type 1 diabetes mellitus	1.35e-05	0.000302	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—INS—type 1 diabetes mellitus	1.32e-05	0.000295	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.3e-05	0.000292	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.3e-05	0.000291	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.29e-05	0.000289	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.28e-05	0.000286	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.27e-05	0.000284	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—CAT—type 1 diabetes mellitus	1.26e-05	0.000283	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.2e-05	0.00027	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.18e-05	0.000265	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.18e-05	0.000264	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.16e-05	0.000259	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CASP3—type 1 diabetes mellitus	1e-05	0.000225	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—IL2—type 1 diabetes mellitus	1e-05	0.000225	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—IL6—type 1 diabetes mellitus	9.98e-06	0.000223	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—IL6—type 1 diabetes mellitus	9.93e-06	0.000222	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CASP3—type 1 diabetes mellitus	9.82e-06	0.00022	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—IL2—type 1 diabetes mellitus	9.81e-06	0.00022	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—IL6—type 1 diabetes mellitus	9.76e-06	0.000219	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—STAT3—type 1 diabetes mellitus	8.44e-06	0.000189	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—INS—type 1 diabetes mellitus	8.38e-06	0.000188	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—STAT3—type 1 diabetes mellitus	8.25e-06	0.000185	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—ALB—type 1 diabetes mellitus	7.69e-06	0.000172	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—EGFR—type 1 diabetes mellitus	7.67e-06	0.000172	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—EGFR—type 1 diabetes mellitus	7.5e-06	0.000168	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—NOS3—type 1 diabetes mellitus	7.35e-06	0.000165	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—IL6—type 1 diabetes mellitus	5.89e-06	0.000132	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—IL6—type 1 diabetes mellitus	5.76e-06	0.000129	CbGpPWpGaD
